Regulations concerning the handling and management of data from "small" computerised systems?
Recommendation

22/23 September 2026
Are regulations necessary for the handling and management of data generated by small systems (e.g. pH meters, filter integrity testers, etc.)? As a rule, GMP-relevant data must be documented. It doesn't matter if this data is generated by large or small systems. Basically, the handling of this data must be regulated.
GMP-relevant data from small computerised systems may have to be read directly from the device and written down by hand. If the system has a printer interface, this interface should also be used. This is an essential step to ensure data integrity.
This also means that when purchasing such small systems, one should already make sure that they have a printer interface. The printer ensures an independent and correct recording of the data when the system is qualified. Raw data is demonstrably available:
MHRA 'GxP' Data Integrity Guidance und Definitions from March 2018:
6.2 "In the case of basic electronic equipment that does not store electronic data,or provides only a printed data output (e.g. balances or pH meters), then the printout constitutes the raw data."
Especially with small systems, it is possible to manipulate data. Restrictive requirements for the handling and documentation of such data are mandatory.
The MHRA 'GXP' Data Integrity Guidance and Definitions document from March 2018, for example, refers to this risk:
4.3 "Within these systems, it may be possible to manipulate data or repeat testing to achieve the desired outcome with limited opportunity for detection (e.g. stand-alone systems with a user-configurable output such as ECG machines, FTIR, UV spectrophotometers)."
Source: MHRA 'GxP' Data Integrity Guidance and Definitions from March 2018
Related GMP News
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?

